Entrepreneur, former fund manager, active independent trader, trading mostly the US equity market via stocks, ETFs and options, following closely the syndicate calendar for IPOs and secondary deals. Frenchman. Active in markets for more than 15 years
Primary interest is Bio with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions as long unless there is negative data, mgmt. concerns, or known negative events. Most funds secured in MFs and divvies though.